Limited M1 Disease: A Significant Prognostic Factor for Stage IV Breast Cancer
- 3 April 2012
- journal article
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 19 (9) , 3028-3034
Abstract
The prognosis of patients with breast cancer presenting with distant metastasis can vary depending on disease extent. This study evaluates a definition of limited M1 disease in association with survival in a cohort of women presenting with metastatic breast cancer. The study cohort comprised 692 women referred to the BC Cancer Agency between 1996 and 2005 with M1 breast cancer at presentation. Limited M1 disease was defined as n = 233) versus extensive (n = 459) M1 disease. Multivariable analysis was performed by Cox regression modeling. Median follow-up time was 1.9 years. Five-year Kaplan-Meier OS was significantly higher in patients with limited compared to extensive M1 disease (29.7 vs. 13.1 %, p < 0.001). In the multivariable Cox regression analysis, limited M1 disease was significantly associated with OS (hazard ratio 0.51, 95 % confidence interval 0.40–0.66, p < 0.001). The only patient subsets with limited M1 disease with poor 5-year OS <15 % were patients with Eastern Cooperative Oncology Group performance status of ≥2 or estrogen receptor-negative status. Limited M1 disease, defined as <5 metastatic lesions confined to one anatomic subsite, is a relevant favorable prognostic factor in patients with stage IV breast cancer. This definition may be used in conjunction with other clinicopathologic factors to select patients for more aggressive systemic and locoregional treatments.Keywords
This publication has 31 references indexed in Scilit:
- Can Locoregional Treatment of the Primary Tumor Improve Outcomes for Women With Stage IV Breast Cancer at Diagnosis?International Journal of Radiation Oncology - Biology - Physics (IJROBP), 2012
- Does metastasectomy improve survival in patients with stage IV melanoma? a cancer registry analysis of outcomesJournal of Surgical Oncology, 2011
- Surgical resection of the primary tumour is associated with improved survival in patients with distant metastatic breast cancer at diagnosisEuropean Journal of Surgical Oncology, 2009
- Breast Cancer With Synchronous Metastases: Survival Impact of Exclusive Locoregional RadiotherapyJournal of Clinical Oncology, 2009
- Oligometastatic breast cancer treated with curative-intent stereotactic body radiation therapyBreast Cancer Research and Treatment, 2008
- Association of Surgery With Improved Survival in Stage IV Breast Cancer PatientsAnnals of Surgery, 2008
- Complete Excision of Primary Breast Tumor Improves Survival of Patients With Metastatic Breast Cancer at DiagnosisJournal of Clinical Oncology, 2006
- Prognostic Model for Relapse After High-Dose Chemotherapy With Autologous Stem-Cell Transplantation for Stage IV Oligometastatic Breast CancerJournal of Clinical Oncology, 2002
- Characterisation of complete responders to combination chemotherapy for advanced breast cancer: A retrospective EORTC breast group studyEuropean Journal of Cancer, 1996
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987